Malignant Biliary Obstruction Clinical Trial
— B-GOODOfficial title:
Palliation of Gastric Outflow Obstruction in Case of Concomitant Biliary Obstruction. A Retrospective, Multicenter Study. (B-GOOD Study).
EUS-guided drainages has been largely widespread during the last 10 years, even thanks to the advent of dedicated devices, such as lumen apposing metal stents (LAMSs). Above all, EUS-guided choledochoduodenostomy (EUS-CD) is to date considered a valuable option of treatment in case of distal malignant biliary obstruction in case of failure of endoscopic retrograde cholangiopancreatography (ERCP) due to the presence of a gastric or duodenal obstruction, unreachable papilla in case of altered anatomy, infiltrated papilla or failure of deep cannulation of the common bile duct. This modality of drainage demonstrated satisfying results, with high rate both of technical and clinical success with acceptable rate of adverse events. When the distal malignant biliary obstruction is associated to signs and symptoms of gastric outflow obstruction (GOO) due to the presence of a gastric or duodenal stenosis, a concomitant or subsequent palliation of the stenosis may be required. Recently, EUS-guided gastroenterostomy (EUS-GEA) has been introduced for the palliation of GOO, showing good results although technically challenging. To date, endoscopic treatment in case of GOO, enteral stenting and EUS-GEA are possible alternatives. However, available data demonstrated that EUS-GEA seems to be superior to enteral stenting in terms of rate of reinterventions during long-term follow-up, especially when life expectancy is superior to 6 months. However, data are lacking regarding which is the best strategy when GOO is associated to distal malignant biliary obstruction, especially when EUS-CD is performed. This is an hot topic, as it has been supposed that EUS-CD has higher rate of adverse events, especially food impaction, when a duodenal stenosis is present. The aim of our study, therefore, is to perform a retrospective multicenter study collecting all consecutive patients affect by distal malignant biliary obstruction drained using EUS-CD, with associated GOO treated with concomitant or subsequent duodenal stenting or EUS-GEA, in order to evaluate clinical efficacy, long term outcomes and severity of adverse events.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | September 30, 2022 |
Est. primary completion date | September 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - patients undergoing affected by distal malignant biliari obstruction and gastric outflow obstruction undergone EUS-CD and EUS-GEA or enteral stenting drainage between January 2016 to September 2021 Exclusion Criteria: - Age under 18 - Enteral stenting or EUS-GEA performed before EUS-CD - Provide an estimate of number of records you plan to review and time period that it will be covered.January 2016 to September 2021 - If the number of records you plan to exceeds 500, please provide the following: N/A - Provide an estimate of how long it will take you to complete the study, including the time for data analysis. 3 month for data collection and 3 weeks for data analysis |
Country | Name | City | State |
---|---|---|---|
Italy | Department of Gastroenterology, Humanitas Research Hospital | Rozzano | Milano |
Lead Sponsor | Collaborator |
---|---|
Istituto Clinico Humanitas |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical success for EUS-CD | Decreased of total bilirubin > 50% or normalization of bilirubin within 2 weeks | 6 Months | |
Primary | Clinical success for EUS-GEA and enteral stenting | resolution of symptoms of GOO, with improvement in enteral diet assumption (creamy or solid) comparing to the baseline | 6 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04941924 -
The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.
|
N/A | |
Active, not recruiting |
NCT03672019 -
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage
|
||
Recruiting |
NCT05220475 -
A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent
|
N/A | |
Completed |
NCT02001779 -
IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT06375954 -
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
|
N/A | |
Not yet recruiting |
NCT06375928 -
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
|
N/A | |
Recruiting |
NCT05786326 -
Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT06375967 -
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
|
N/A | |
Completed |
NCT01869894 -
A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT05804201 -
EUS-guided Hepatico-gastrostomy With Hot Giobor
|
N/A | |
Recruiting |
NCT01686425 -
Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage
|
N/A | |
Recruiting |
NCT03215108 -
Comparison Between Novel Flower-type Covered Stent and Conventional Covered Stent
|
N/A | |
Recruiting |
NCT04898777 -
EUS-Guided Choledochoduodenostomy Versus ERCP for Primary Biliary Decompression in Distal Malignant Biliary Obstruction
|
N/A | |
Recruiting |
NCT05169398 -
EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent
|
N/A | |
Enrolling by invitation |
NCT05233293 -
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
|
N/A | |
Completed |
NCT03812250 -
EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction
|
N/A | |
Completed |
NCT03000855 -
EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures
|
Phase 2/Phase 3 | |
Recruiting |
NCT01073514 -
Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction
|
N/A | |
Recruiting |
NCT05729867 -
Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC
|
N/A | |
Completed |
NCT04405752 -
Evaluation of a New Metal Biliary Stent of 12-mm Diameter: a Case Control Study
|